Description
The National Institutes of Health (NIH) is seeking a non-competitive combined synopsis/solicitation to acquire Oxford Nanopore PromethION Flow Cells and cDNA-PCR Sequencing Kits. The purpose of this acquisition is to support the National Institute on Aging's Center for Alzheimer's Disease and Related Dementias (CARD) long-read RNA sequencing project on ROSMAP brain samples. The required items include FLO-PRO114M - PromethION Flow Cells Packs (DNA) and SQK-PCS114 - cDNA-PCR Sequencing Kit V14. The period of performance is from June 10, 2026, to December 10, 2026. The following are key points to consider:
* The acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services.
* The solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation.
* The NIH intends to negotiate and award a Firm-Fixed-Price purchase order to Oxford Nanopore Technologies Inc.
* The required items are proprietary and can only be provided by Oxford Nanopore Technologies Inc.
* The period of performance is approximately 6 months.